CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today reported financial results for the quarter ended June 30, 2015.
Mark Perrin, Chief Executive Officer and Chairman, said, “InVivo made significant advancements across all fronts during the second quarter. The three patients in our ongoing clinical trial continued to make meaningful motor and sensory improvements. We added two new clinical sites, one of which is a federally designated Spinal Cord Injury Model Systems center.
Help employers find you! Check out all the jobs and post your resume.
